http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102005054454-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6f677855b41682531902de49afbd5fa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-012 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24 |
| filingDate | 2005-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e100fb017f8c8deb03a3b819281363f7 |
| publicationDate | 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102005054454-A1 |
| titleOfInvention | Use of chorionic gonadotropin as immunosuppressant |
| abstract | objectnthe invention is the use of at least one proteohormone,nin particular glycoprotein hormones, preferably a gonadotropicnHormones (gonadotropins), more preferably of particular humannChorionic gonadotropin (HCG), as immunosuppressant or for productionna drug for immunosuppression, being used as indications in particularnthe treatment of autoimmune diseases and the treatment ofnTransplant rejection,nespecially host-versus-graft reactions ("host-versus-graftnreaction ") or graft-versus-host reactions (" graft-versus-hostndisease [= GVHD] ") after transplantation. |
| priorityDate | 2005-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 373.